title: What Happens When Imatinib Goes Generic?
authors: Jean
authors: J
authors: McDougall
authors: Scott D
authors: SD
authors: Ramsey
authors: Jerald
authors: J
authors: Radich
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D000068877:Imatinib Mesylate / Q000191:economics / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000191:economics / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D016568:Drugs, Generic; D047428:Protein Kinase Inhibitors; D000068877:Imatinib Mesylate